CorMedix Inc. (NASDAQ:CRMD) Q1 2021 Results Conference Call May 13, 2021 4:30 PM ET Company Participants Daniel Ferry - Investor Relations Khoso Baluch - Chief Executive Officer Thomas Nusbickel - Executive Vice President and Chief Commercial Officer Phoebe Mounts - Executive Vice President and General Counsel Elizabeth Masson-Hurlburt - Executive Vice President for Clinical Operations Matthew David - Executive Vice President and Chief Financial Officer Conference Call Participants Jason Butler - JMP Securi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Delaware 20-5894890 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file numb ...

& CorMedix™ Corporate Presentation April 2021 DefenCath™: A potentially new standard-of-care in the prevention of catheter related blood stream infections Forward-Looking Statements This presentation contains certain statements that constitute forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are not guarantees of future performance a ...

CorMedix Inc. (NASDAQ:CRMD) Q4 2020 Earnings Conference Call March 30, 2021 4:30 PM ET Company Participants Dan Ferry - Investor Relations Khoso Baluch - Chief Executive Officer Phoebe Mounts - Executive Vice President & General Counsel Matt David - Executive Vice President & Chief Financial Officer Conference Call Participants Jason Butler - JMP Securities Joon Lee - Truist Securities Chad Messer - Needham & Company Andrew D'Silva - B. Riley & Company Operator Greetings. Welcome to the CorMedix Fourth Quar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ______________________ Commission file number: 001-34673 CORMEDIX INC. (Exact name of Registrant as Specified in Its Charter) | --- | --- | |-------- ...

CorMedix Inc. (NASDAQ:CRMD) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Dan Ferry - Investor Relations Khoso Baluch - Chief Executive Officer Phoebe Mounts - Executive Vice President and General Counsel Matt David - Executive Vice President and Chief Financial Officer Conference Call Participants Jason Butler - JMP Securities Operator Greetings and welcome to the CorMedix Inc. Third Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, this conference is be ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-34673 CORMEDIX INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |------------------- ...

CorMedix Inc. (NASDAQ:CRMD) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors Khoso Baluch – Chief Executive Officer Phoebe Mounts – Executive Vice President and General Counsel Matt David – Executive Vice President and Chief Financial Officer Conference Call Participants Andrew D'Silva – B. Riley FBR Ram Selvaraju – H.C. Wainwright Operator Greetings, and welcome to the CorMedix, Inc. Second Quarter 2020 Earnings Call. At this ti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-34673 CORMEDIX INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |------------------------ ...

CorMedix, Inc. (NASDAQ:CRMD) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Daniel Ferry - LifeSci Advisors Khoso Baluch - CEO & Director Matt David - EVP & CFO Phoebe Mounts - EVP, General Counsel, Secretary & Head, Regulatory, Compliance and Legal Paul Chew - Acting Chief Medical Officer Conference Call Participants Andrew D'Silva - B. Riley FBR Operator Good day, everyone, and welcome to the CorMedix Inc. First Quarter 2020 Earnings Conference Call. Today's call is being re ...